Lynda Bryant-Comstock

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi request reprint Health care utilization and costs among privately insured patients with bipolar I disorder
    Lynda Bryant-Comstock
    GlaxoSmithKline Research and Development, Global Health Outcomes, Research Triangle Park, NC 27709, USA
    Bipolar Disord 4:398-405. 2002
  2. ncbi request reprint Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysis
    Monika Stender
    GlaxoSmithKline Research and Development, Greenford, Middlesex, United Kingdom
    Clin Ther 24:1668-76. 2002

Collaborators

  • Monika Stender
  • Seren Phillips

Detail Information

Publications2

  1. ncbi request reprint Health care utilization and costs among privately insured patients with bipolar I disorder
    Lynda Bryant-Comstock
    GlaxoSmithKline Research and Development, Global Health Outcomes, Research Triangle Park, NC 27709, USA
    Bipolar Disord 4:398-405. 2002
    ..This study examined health care resource utilization and direct health care costs among patients diagnosed with bipolar I disorder in a privately insured population...
  2. ncbi request reprint Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysis
    Monika Stender
    GlaxoSmithKline Research and Development, Greenford, Middlesex, United Kingdom
    Clin Ther 24:1668-76. 2002
    ..Detailed assessments of the direct costs related to bipolar disorder and of the burden it places on the health care system are limited...